Benefits and Risks of Newborn Screening for Cystic Fibrosis

Plain-language summary

This study evaluates the benefits and risks of newborn screening for Cystic Fibrosis. It included people born in Wisconsin between 1985 and 1994 who had a valid screening test. It is an observational (non-phase) study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Intervention

CF newborn screening

Countries

United States

Related genes

Locations

• Madison, United States
• Milwaukee, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Must have been born in the State of Wisconsin
* Must have been born between April 15, 1985 and June 30, 1994
* Must have had a valid newborn screening test for cystic fibrosis in the first 28 days of life.
* Must have a sweat chloride test greater or equal to 60 mmol/Liter
* Parental consent